about
Plant sterols and cardiovascular disease: a systematic review and meta-analysisRationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).Do inter-hospital comparisons of in-hospital, acute myocardial infarction case-fatality rates serve the purpose of fostering quality improvement? An evaluative study.Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.Plant and animal protein intake and its association with overweight and obesity among the Belgian population.ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collabRisk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis.Evidence-based goals versus achievement in clinical practice in secondary prevention of coronary heart disease: findings in EUROASPIRE II.2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.Dietary sources of fiber intake and its association with socio-economic factors among Flemish preschool children.Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.C-reactive protein levels in patients at cardiovascular risk: EURIKA studyAchievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyThe relation of ambulatory heart rate with all-cause mortality among middle-aged men: a prospective cohort studyDietary sources of animal and plant protein intake among Flemish preschool children and the association with socio-economic and lifestyle-related factorsPatients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.Dietary sources of energy and macronutrient intakes among Flemish preschoolers.Occupational and leisure time physical activity in contrasting relation to ambulatory blood pressurePrevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular PharmacoloEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituteEuropean guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by repEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary.The SCORE model in the POWER study: an attempt to focus the limited resources for prevention on patients with greatest need.Food intakes by preschool children in Flanders compared with dietary guidelines.Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.Associations between dimensions of job stress and biomarkers of inflammation and infection.Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constitutedDo novel biomarkers add to existing scores of total cardiovascular risk?Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.Cardiovascular risk factors: Belgian target achievement.The association between blood pressure and lipid levels in Europe: European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice.Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
P50
Q24632486-DE48C4AC-0C37-4F23-BE74-24277D0854C9Q33621905-0E285613-6A03-450B-89CC-AEB9F0D60DFFQ33766878-4FA9D843-2761-4C31-8849-4B6044E0306EQ33808302-A014A325-35B6-4126-ACE3-13F743A259EEQ33996248-24133523-B092-4E39-969C-4DC5E3313BF5Q34020986-049D8721-61FD-42F4-8029-D3C08EAC6BF7Q34153992-0F9494B9-AFE3-43F6-A5A9-58AA937B7D4EQ34196167-12A221A2-9939-402C-8AC7-4554A6EC655CQ34351265-35B771D1-5414-4908-936B-CF490B9A1983Q34368081-50534C4B-96F1-4693-A0FC-DE80B958AC70Q34563461-B6E3BAF3-12C9-4E88-8B8F-9E6D4861340CQ34614349-A3DCDEED-F5AB-48BD-88A0-7E8C8819813BQ34636529-237BD9EA-6581-4237-B214-D262627D2EE5Q34673532-78E69D0D-06B1-41DD-8798-8E496B7F976FQ35036065-614AF3B2-7BA0-4A80-B4DF-F60C526A97A4Q35097138-C51BDAE8-A6A3-4886-A40B-8CA5B4311D99Q35101153-F88DE9B3-90B6-440C-BC8B-B1F10749FFBCQ35187425-A98EE538-8133-4321-A51A-A52E9F61BC8DQ35220041-2AD71AAD-B3C7-4A5E-9233-1708D76D12BFQ35320944-1C296652-EBEE-4D6A-A436-5A16A2856848Q36115574-A3937493-5225-4365-B7E6-CB71C92FA8F9Q36217709-B845358C-704F-4ED8-A9B5-C2680986B4CFQ36552621-94D0D36E-234F-46C1-A2E7-9B5955542B4FQ36613362-883CA62F-34A0-4FF4-9E91-C1E4074BD486Q36921887-A6E4DDA3-B364-4C28-8510-2EEF9251806EQ36921892-3CB7B861-ED9B-404A-9F2C-4B31521148A7Q36946180-F68847FA-6CB1-4048-9225-F45AF7C09820Q37037830-E0A24998-B9A8-4C61-877F-906F44399F1AQ37167059-C65384E8-BFA2-445A-A5EE-FB155E255786Q37517330-5A0BF411-4909-43C6-B0F5-0544D56061E7Q37538081-2BD5D1C1-8300-4282-85A2-59DC868EB5A3Q37863969-142B1ACD-37A0-4FA1-8C6E-A74378251B1AQ37872566-4B050487-A8DE-4B6A-8283-39FFED4CEE5FQ37973386-D453D446-9920-41CA-B5D9-EA5C413B6E38Q38018762-A146F37C-0CD6-40A3-8E32-81D3F5A3FD1AQ38026699-21A63F30-B470-41EC-AB59-0D08E09C2A06Q38182218-84EFAA06-D202-4B77-8F5C-D4898C5B1A68Q38339184-FF0F4F49-F43B-473E-B94C-CEE26A559B4EQ38389003-9E7C393B-7809-4374-8FBB-657ECE094C0CQ38492555-16CF81A4-4C66-4FA5-8824-718ABEFDE9B8
P50
name
Guy De Backer
@ast
Guy De Backer
@en
Guy De Backer
@nl
type
label
Guy De Backer
@ast
Guy De Backer
@en
Guy De Backer
@nl
prefLabel
Guy De Backer
@ast
Guy De Backer
@en
Guy De Backer
@nl